Lannett Company Inc (LCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCI | CANF | XBIO | ||
| Company | Lannett Company Inc | Can-Fite Biopharma Ltd ADR | Xenetic Biosciences Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE Arca | NASDAQ | ||
| Open | 0.6500 | 2.16 | 3.73 | ||
| High | 0.7196 | 2.16 | 3.73 | ||
| Low | 0.6500 | 2.00 | 3.65 | ||
| Last | 0.6855 | 2.03 | 3.65 | ||
| Change | +0.0255 | -0.12 | unch | ||
| % Change | +3.86% | -5.58% | unch | ||
| Volume | 280,600 | 64,058 | 3,705 | ||
| 20-Day Average Volume | 123,065 | 82,512 | 7,630 | ||
| Previous Close | 0.6600 | 2.15 | 3.65 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.1762 | 2.28 | 3.91 | ||
| 20-Day Raw Stochastic | 3.83% | 6.08% | 6.76% | ||
| 20-Day Relative Strength | 27.93% | 38.29% | 46.37% | ||
| Weighted Alpha | -68.87 | -52.39 | -38.97 | ||
| Today's Opinion | 88% Sell | 40% Sell | 40% Sell | ||
| Previous Opinion | 88% Sell | 40% Sell | 24% Sell | ||
| Last Month's Opinion | 40% Sell | 8% Sell | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.55% since 04/12/23 | -16.79% since 09/12/24 | -5.07% since 09/12/24 | ||
| Low | 0.6375 on 04/14/23 | 2.00 on 09/19/24 | 3.60 on 09/18/24 | ||
| High | 0.7200 on 04/14/23 | 2.50 on 09/13/24 | 4.13 on 09/13/24 | ||
| 1-Month | |||||
| %Chg | -58.45% since 03/17/23 | -16.30% since 08/19/24 | -2.82% since 08/19/24 | ||
| Low | 0.6375 on 04/14/23 | 2.00 on 09/19/24 | 3.60 on 09/18/24 | ||
| High | 1.8900 on 04/03/23 | 2.50 on 09/13/24 | 4.34 on 08/26/24 | ||
| 3-Month | |||||
| %Chg | -72.78% since 01/19/23 | -25.63% since 06/18/24 | -8.52% since 06/18/24 | ||
| Low | 0.6375 on 04/14/23 | 2.00 on 09/19/24 | 2.78 on 08/06/24 | ||
| High | 3.2500 on 02/07/23 | 4.69 on 07/22/24 | 5.20 on 08/05/24 | ||
| 6-Month | |||||
| %Chg | -57.61% since 10/19/22 | -6.86% since 03/19/24 | -14.12% since 03/19/24 | ||
| Low | 0.6375 on 04/14/23 | 1.91 on 04/26/24 | 2.78 on 08/06/24 | ||
| High | 3.7200 on 12/21/22 | 4.69 on 07/22/24 | 5.20 on 08/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,381 | 7,611 | 5,624 | ||
| Shares Outstanding, K | 10,767 | 3,540 | 1,541 | ||
| Annual Sales | 340,580,000 | 740,000 | 2,540,000 | ||
| Annual Net Income | -231,620,000 | -7,630,000 | -4,130,000 | ||
| Last Quarter Sales | 80,890,000 | 160,000 | 730,000 | ||
| Last Quarter Net Income | -36,310,000 | -1,650,000 | -1,270,000 | ||
| 60-Month Beta | 0.95 | 1.41 | 2.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.36 on 02/01/23 | -0.31 on 03/28/24 | -0.83 on 08/13/24 | ||
| Latest Earnings Date | 05/03/23 | 09/19/24 | 11/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||